Feed / MTD

Mettler-Toledo International Inc.

MTD

Healthcare · 1,278.66 -0.9% today

Isolated · not yet confirmedMarket checked 10 Sept, 15:55 GMT-4

Market read

Mettler-Toledo International Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 39 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

Company-0.9% todayVolume comparison unavailable
Market group0 of 39 activeDiagnostics & Defense · unavailable
Disclosed network0 of 2 confirmingNo filing-linked name is confirming now
What would change this read
  • MTD's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if MTD's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Diagnostics & Research

No new filing conclusion is available. 0 of 39 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • MTD's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations601
Usable filing statements28
Verified relationships1
Evidence supporting the case

No qualifying supportive evidence was identified.

Evidence challenging the case
  • Tariffs and trade policy has repeated adverse evidence across 5 filings.
Questions before a position

No credible peer-relative valuation comparison is available yet.

Longer-term price context

Price as of Sep 10, 2026

1,278.66
6m+4.0%12m-0.5%24m-7.8%
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$3.7B+20.5%$32.78-3.1%
2022-12-31$3.9B+5.4%$38.41-3.2%
2023-12-31$3.8B-3.4%$35.90-3.3%
2024-12-31$3.9B+2.2%$40.48-3.0%
2025-12-31$4.0B+4.0%$42.05-3.0%

What management says matters

Persistent and emerging business drivers

Tariffs and trade policymixed · 5 filings
Excluding the effect of the one-time tariff-related U.S.
10-Q · Jul 31, 2026
Capital investment and capacitymixed · 1 filings
Capital expenditures in 2026 42 Table of Contents are expected to approximate $130 million subject to business and economic conditions and foreign currency fluctuations.
10-K · Feb 6, 2026
Foreign exchangemixed · 1 filings
Capital expenditures in 2026 42 Table of Contents are expected to approximate $130 million subject to business and economic conditions and foreign currency fluctuations.
10-K · Feb 6, 2026
Macroeconomic conditionsmixed · 1 filings
Our share repurchase program does not obligate us to acquire any specific number of shares; however, in 2026, we intend to spend in the range of $825 million to $875 million on the repurchase of shares, subject to business and economic conditions.
10-K · Feb 6, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 6.6× · EV/sales 7.1×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

1,278.66-0.9% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for MTD. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for MTD. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind MTD

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 2 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

MTD is currently a Follower in the organic co-movement group Diagnostics & Defense. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.

This group is retained as the last observed read for MTD; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.